Clinical Trials Corner: Contact After the First Round.
- Published in:
- Kidney Cancer (2468-4562), 2021, v. 5, n. 3, p. 165, doi. 10.3233/KCA-210001
- By:
- Publication type:
- Article
Works matching IS 24684562 AND DT 2021 AND VI 5 AND IP 3
Results: 6
1
2
First-Line Immunotherapy Combinations in Advanced Renal Cell Carcinoma: A Rapid Review and Meta-Analysis.
- Published in:
- Kidney Cancer (2468-4562), 2021, v. 5, n. 3, p. 153, doi. 10.3233/KCA-210120
- By:
- Publication type:
- Article
3
Active Surveillance of Small Renal Masses: A Systematic Review.
- Published in:
- Kidney Cancer (2468-4562), 2021, v. 5, n. 3, p. 139, doi. 10.3233/KCA-210114
- By:
- Publication type:
- Article
4
Defining the Optimal Management Strategy for Small Renal Masses.
- Published in:
- Kidney Cancer (2468-4562), 2021, v. 5, n. 3, p. 137, doi. 10.3233/KCA-200008
- By:
- Publication type:
- Article
5
Real-World Utilization of Oral Anticancer Agents and Related Costs in Older Adults with Metastatic Renal Cell Carcinoma in the United States.
- Published in:
- Kidney Cancer (2468-4562), 2021, v. 5, n. 3, p. 115, doi. 10.3233/KCA-210119
- By:
- Publication type:
- Article
6
Bim Expression in Peritumoral Lymphocytes is Associated with Survival in Patients with Metastatic Clear Cell Renal Cell Carcinoma.
- Published in:
- Kidney Cancer (2468-4562), 2021, v. 5, n. 3, p. 129, doi. 10.3233/KCA-210116
- By:
- Publication type:
- Article